Discover opportunities months before the RFP drops
Learn more →Retrieving RFP details
Starbridge can help you:
Pain points mentioned in board meetings and strategic plans
Instantly outline and draft all requirements
Bring in your USPs and exploit competitor gaps
Starbridge can help you:
Get ahead of RFPs — target accounts planning budget or ending contracts soon
Accounts with contract expirations, meetings mentioning your product, grants, budget changes and more
Starbridge.ai books 30 - 40% of leads into meetings
Premium
Access the largest public sector contact database
Premium
Get complete source documentation & analysis
The U.S. Food and Drug Administration (FDA) issued this sources-sought notice to identify suppliers of a closed-filtration sterility pump compatible with Millipore-Sigma Steritest Symbio systems for the Irvine Medical Products Laboratory. The notice specifies technical requirements including a compact design for biosafety cabinets, 316L stainless construction, and vaporized hydrogen peroxide resistance. Capability statements are due by February 2, 2026, and must be submitted via email to the listed point of contact.
Starbridge can help you:
Pain points mentioned in board meetings and strategic plans
Instantly outline and draft all requirements
Bring in your USPs and exploit competitor gaps
Starbridge can help you:
Get ahead of RFPs — target accounts planning budget or ending contracts soon
Accounts with contract expirations, meetings mentioning your product, grants, budget changes and more
Starbridge.ai books 30 - 40% of leads into meetings
Requires an additional closed-filtration sterility pump that is a “Brand Name or Equal” Millipore-Sigma Steritest Symbio Laminar Flow Hood (LFH) pump, to be used in a laminar air flow hood.
Posted Date
Jan 22, 2026
Due Date
Feb 2, 2026
Release: Jan 22, 2026
Close: Feb 2, 2026
Requires an additional closed-filtration sterility pump that is a “Brand Name or Equal” Millipore-Sigma Steritest Symbio Laminar Flow Hood (LFH) pump, to be used in a laminar air flow hood.
AvailableThe U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grant Services, issued a sources-sought/market research notice seeking capability statements for a closed-filtration sterility pump compatible with Millipore-Sigma Steritest Symbio Laminar Flow Hood (LFH) pumps. This is market research only (not a request for proposal or a grant) and vendors are asked to email capability statements including country-of-manufacture information to Warren.Dutter@fda.hhs.gov. Submissions were requested by February 2, 2026, and the notice is a single, active sources-sought opportunity for the FDA on behalf of the Irvine Medical Products Laboratory.
Posted Date
Jan 22, 2026
Due Date
Feb 2, 2026
Release: Jan 22, 2026
Close: Feb 2, 2026
Line Hardware "Brand Name or Equal" - Archer Bushnell Tap.
Posted Date
Jan 15, 2026
Due Date
Jan 29, 2026
Release: Jan 15, 2026
Close: Jan 29, 2026
Line Hardware "Brand Name or Equal" - Archer Bushnell Tap.
AvailableProvide dose calibrator brand name or equal. Qty CRC-55TW with a crc-55tr dos calibrator and caprac-t wipe test counter.
Posted Date
Jan 20, 2026
Due Date
Jan 27, 2026
Release: Jan 20, 2026
Close: Jan 27, 2026
Provide dose calibrator brand name or equal. Qty CRC-55TW with a crc-55tr dos calibrator and caprac-t wipe test counter.
AvailableSurface intent from meeting minutes, budgets, and contract expirations. Influence RFP requirements before competitors ever see them.
See your top 10 upcoming opportunities on a demo →Premium
Access the largest public sector contact database
Premium
Get complete source documentation & analysis
The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grant Services, issued a sources-sought/market research notice seeking capability statements for a closed-filtration sterility pump compatible with Millipore-Sigma Steritest Symbio Laminar Flow Hood (LFH) pumps. This is market research only (not a request for proposal or a grant) and vendors are asked to email capability statements including country-of-manufacture information to Warren.Dutter@fda.hhs.gov. Submissions were requested by February 2, 2026, and the notice is a single, active sources-sought opportunity for the FDA on behalf of the Irvine Medical Products Laboratory.